Cambrex, Catalent, Lonza, Avantor, PCI Pharma Services Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring Cambrex, Catalent, Lonza, Avantor, PCI Pharma Services, MilliporeSigma, Solvias, Avid Bioservices and others. Chemicals/Chemical API Manufacturing Cambrex To Invest $3.6 M to…

Piramal To Acquire Solid-Dosage Mfg Facility; Cytiva, Sharp Expand
By

By
The latest from CDMOs, CMOs, and suppliers featuring Piramal Pharma Solutions, Cytiva, Sharp, Thermo Fisher, Siemens, Evotec, Honeywell, and Bavarian Nordic. Biologics Manufacturing Cytiva Upgrades Massachusetts Contract Biomanufacturing Site Cytiva,…

Fujifilm To Invest $935 M to Expand Large-Scale Biologics Mfg Facility
By

By
Fujifilm Corporation will invest approximately 100 billion Yen ($935 million) in the Denmark site of Fujifilm Diosynth Biotechnologies, its CDMO for biologics and advanced therapies, to double the site’s current…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring Catalent, Fujifilm, PolyPeptide Group, Dyadic International, and SiO2 Material Science. Chemical/Chemical API Manufacturing Novavax Selects PolyPeptide to Manufacture COVID-19…

WuXi Plans Mfg Facility; Alcami’s New CEO; Lonza and 3D Bioprinting
By

By
The latest from CDMOs, CMOs, and suppliers featuring Lonza, WuXi Biologics, Alcami, Sharp, Berkshire Sterile Mfg, Tedor, Packaging Technology Group, and Jones Packaging. Biologics Manufacturing WuXi Biologics Signs Lease for…

AGC Acquires Former AstraZeneca Facility; Cambrex CEO To Retire
By

By
The latest from CDMOs, CMOs, and suppliers featuring Flamma, AGC Biologics, Cambrex, Thermo Fisher, Corning, Evonik, Stevanato Group, and PCI Pharma Services. Chemicals/Chemical API Manufacturing Flamma Starts Construction for a…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring AGC Biologics, Almac, and Advent Srl. Biologics Manufacturing Advent To Manufacture COVID-19 Vaccine for Oxford University Advent Srl, a…

WuXi To Build US Facility; Sharp, Catalent Acquire Packaging Facilities
By

By
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Advanced Therapies, WuXi Biologics, Catalent, Sharp, Colorcon, and Rentschler Biopharma. Biologics Manufacturing WuXi Biologics To Build New Biomanufacturing Facility in…

CDMO, CMO, Supplier Roundup in Supporting COVID-19 Projects
By

By
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring Catalent, Sterling Pharma, ABL, and  Singota. Chemicals/Chemical API Manufacturing Sterling Begins Hydroxychloroquine Production in the UKSterling Pharma Solutions, a Dudley, UK-headquartered CDMO,…

WuXi Acquires Drug-Product Plant; Catalent Expands; Stevanato in Pact
By

By
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Biologics, Catalent, Stevanato, Wasdell, and Evotec. Chemicals/Chemical API Manufacturing Evotec, leon-nanodrugs Enter Pact for Nanomedicine Evotec, a Hamburg, Germany-based drug-discovery…